Form 4: Charles River Labs Executive Shannon M. Parisotto Reports Stock Transactions
SEC Form 4 Filing
Shannon M. Parisotto, CEVP at Charles River Laboratories, reported the disposition of 110 shares of common stock to cover tax obligations and indirectly owns 26,529 shares through Karpathos Investments LLC.
Summary
- On May 29, 2024, Shannon M. Parisotto, a CEVP at Charles River Laboratories International, Inc., reported a transaction involving the company's common stock.
- 110 shares of common stock were disposed of at a price of $214.51 per share.
- Following the transaction, Parisotto directly owns 6,679 shares of common stock.
- Parisotto also indirectly owns 26,529 shares through Karpathos Investments LLC.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by an executive, and doesn't inherently indicate positive or negative sentiment. It's a neutral reporting event.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into the transactions of those with access to non-public information.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of stock transaction (disposal of shares). |
| 05/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.